Improving ILD Diagnosis and Predicting Clinical Progression with the Envisia Genomic Classifier
Presented by: Anna Podolanczuk, MD, MS and Sandeep Bansal, MD, FCCP, FACP
In this webinar, speakers will discuss updated IPF/PPF guidelines, key utility data, and the role of the Envisia Genomic Classifier in the diagnosis and prognosis of ILD. New data will be presented that demonstrates how the Envisia Classifier can predict clinical progression in fibrotic ILD.
Missed us at CHEST 2022?
